Company news
Quantum Biopharma Ltd. Subordinate Voting Shares news in 2020
Quantum Biopharma Ltd. Subordinate Voting Shares's news releases, calls and decks from 2020, newest first.
FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients
September 28, 2020
FSD Pharma Announces Phase 2 Clinical Trial IND Filing with the FDA to Treat Patients with COVID-19
August 31, 2020
FSD Pharma Reports Second Quarter 2020 Financial Results
August 7, 2020
FSD Pharma Inc. Announces Closing of US $10 Million Registered Direct Offering to Institutional Investors
August 6, 2020
FSD Pharma Inc., Developing its PEA Compound to Treat COVID-19, CEO Clip Video
July 31, 2020
FSD Pharma Inc. Announces US$10 Million Registered Direct Offering
July 31, 2020
FSD Pharma Announces Decision to Surrender Health Canada Licenses for Subsidiary FV Pharma Inc.
July 30, 2020
FSD Pharma Announces US$20M At-The-Market Offering
July 13, 2020
InvestmentPitch Media Video Discusses FSD Pharma's Report of Favorable Topline Results from Phase 1 First-in-Human Safety and Tolerability Study of Ultra-micronized PEA - Video Available on Investmentpitch.com
June 23, 2020
FSD Pharma Announces Closing of C$10.125 Million Private Placement to Institutional Investors
June 9, 2020
FSD Pharma Inc. Announces C$10.125 Million Private Placement
June 4, 2020
FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis
June 3, 2020
FSD Pharma Reports First Quarter 2020 Financial Results
May 14, 2020
FSD Pharma Takes Steps to Mitigate the Impact of COVID-19 on its Cannabis Production Facility in Cobourg, Ontario
March 23, 2020
InvestmentPitch Media Video Discusses FSD Pharma's Initiation of Phase 1 In-Human Safety & Tolerability Study of Dosing Ultra Micro-PEA for Targeting CB2 Receptors at Alfred Hospital in Australia - Video Available on Investmentpitch.com
March 10, 2020
FSD Pharma Begins Phase 1 In-human Safety and Tolerability Study of Ultra Micro-Palmitolylethanolamide (PEA)
March 9, 2020
FSD Pharma Inc., Worldwide License of Natural Fatty Acid, CEO Clip Video
March 6, 2020
FSD Pharma to Ring the Opening Bell of the Canadian Securities Exchange on Friday, March 6, 2020
March 4, 2020
InvestmentPitch Media Video Discusses FSD Pharma's Sale of its 12% Interest in Cannara Biotech Generating 670% Return and $7.7 million in Proceeds - Video Available on Investmentpitch.com
February 24, 2020
FSD Pharma CEO, Dr. Raza Bokhari, Discusses 2020 Goals with The Stock Day Podcast
February 11, 2020
FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC
February 5, 2020
FSD Pharma and Solarvest Enhance Commitment to CBD Research Project
February 4, 2020
FSD Pharma to Ring Nasdaq Opening Bell on Wednesday, January 22, 2020
January 17, 2020
InvestmentPitch Media Video Discusses FSD Pharma's New Listing on the Nasdaq Capital Market and Upcoming Biotech and Healthcare Conferences - Video Available on Investmentpitch.com
January 10, 2020
FSD Pharma to Commence Trading on Nasdaq Capital Market Under Symbol 'HUGE'
January 9, 2020
FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol 'HUGE' on January 9, 2020
January 6, 2020
FSD Pharma Strengthens Management Team
January 2, 2020